Trademark: 90218072
Word
CIPLA THERAPEUTICS
Status
Pending
Status Code
733
Status Date
Thursday, October 12, 2023
Serial Number
90218072
Mark Type
3000
Filing Date
Monday, September 28, 2020
Published for Opposition
Tuesday, August 24, 2021

Trademark Owner History
CIPLA LIMITED - Owner At Publication

Classifications
5 Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of gastro-intestinal disorders, disorders of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, seizures Huntington's disease, multiple sclerosis; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, namely, Coronary artery disease, Heart attack, abnormal heart rhythms, arrhythmias, heart failure, heart valve disease, congenital heart disease, cardiomyopathy, pericardial disease; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of migraines and other forms of headache, namely, sinus headaches, tension headaches, cluster headaches and rebound headaches; pharmaceutical and medicinal preparations, namely, analgesics; pharmaceutical and medicinal preparations, namely, antiviral and anti-retroviral pharmaceutical preparations for the treatment of viral brain diseases; pharmaceutical and medicinal preparations, namely, anti-infectives; pharmaceutical and medicinal preparations, namely, anti-inflammatories; pharmaceutical and medicinal preparations, namely, antibiotics; pharmaceutical and medicinal preparations, namely, antidepressants; pharmaceutical and medicinal preparations, namely, anti-cancer preparations; pharmaceutical and medicinal preparations, namely, medicated soaps and lotions for the skin and hair, namely, medicated acne lotion, medicated body moisturizing lotion, medicated lotion for eczema and seborrheic dermatitis, medicated hair shampoo and hair scalp lotion, medicated anti-dandruff lotion; pharmaceutical and medicinal preparations, namely, decongestants and antihistamines; pharmaceutical and medicinal preparations, namely, scabicides; pharmaceutical and medicinal preparations, namely, anti-malarials; pharmaceutical and medicinal preparations, namely, cough suppressants; pharmaceutical and medicinal preparations, namely, cough and cold preparations; pharmaceutical and medicinal preparations, namely, expectorants; pharmaceutical and medicinal preparations, namely, anti-leukemic agents; pharmaceutical and medicinal preparations, namely, tissue sealants; pharmaceutical and medicinal preparations, namely, vasopressors; pharmaceutical and medicinal preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; pharmaceutical and medicinal preparations, namely, preparations for the treatment of gout; pharmaceutical and medicinal preparations, namely, preparations for cessation of smoking; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of genitourinary diseases and disorders, namely, urological diseases, urological disorders, urinary incontinence, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of pain from burns, hemolytic diseases and disorders, neuropathic pain; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of fibromyalgia, post-herpetic neuralgia, chronic pain, obesity, inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), viral diseases and disorders, namely, herpes, hepatitis, substance abuse disorders, namely, alcoholism and drug addiction, carpel tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, yeast infections, prostate disorders, pulmonary disorders, sleep disorders, namely, insomnia and, restless leg syndrome, premature ejaculation, macular degeneration, thrombosis and thromboembolism; pharmaceutical and medicinal preparations, namely, vaccines for human use; pharmaceutical and medicinal preparations, namely, adjuvants for use with human vaccines; pharmaceutical and medicinal preparations in the nature of veterinary preparations, namely, flea and tick preparations, vaccines, anti inflammatories, mastitis preparations, and oncological preparations
44 Medical care services; medical treatment services for the treatment, alleviation and prevention of gastro-intestinal disorders, disorders of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, seizures Huntington's disease, multiple sclerosis, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, namely, coronary artery disease, heart attack, abnormal heart rhythms, arrhythmias, heart failure, heart valve disease, congenital heart disease, cardiomyopathy, pericardial disease, migraines and other forms of headache, namely, sinus headaches, tension headaches, cluster headaches and rebound headaches, genitourinary diseases and disorders, namely, urological diseases, urological disorders, urinary incontinence, infertility, sexually transmitted diseases, inflammatory pelvic diseases; and medical treatment services for treatment, alleviation and prevention of pain from burns, hemolytic diseases and disorders, neuropathic pain; fibromyalgia, post-herpetic neuralgia, chronic pain, obesity, inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), viral diseases and disorders, namely, herpes, hepatitis, substance abuse disorders, namely, alcoholism and drug addiction, carpel tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, yeast infections, prostate disorders, pulmonary disorders, sleep disorders, namely, insomnia and, restless leg syndrome, premature ejaculation, macular degeneration, thrombosis and thromboembolism
The mark consists of the word "CIPLA" in stylized blue font positioned above the word "THERAPEUTICS" in stylized turquoise font with the image of the a semi-circle composed of three separate semi-circles, in blue and turquoise, which is positioned to the left of the wording. White is used for the background but is not claimed as a feature of the mark.
The color(s) blue and turquoise is/are claimed as a feature of the mark.
"THERAPEUTICS"

Trademark Events
Oct 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 12, 2023
Sou Extension 4 Granted
Oct 12, 2023
Sou Extension 4 Filed
Oct 12, 2023
Sou Teas Extension Received
Apr 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 13, 2023
Sou Extension 3 Granted
Apr 13, 2023
Sou Extension 3 Filed
Apr 13, 2023
Sou Teas Extension Received
Oct 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 18, 2022
Sou Extension 2 Granted
Oct 18, 2022
Sou Extension 2 Filed
Oct 18, 2022
Sou Teas Extension Received
Jul 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2022
Sou Extension 1 Granted
Apr 19, 2022
Sou Extension 1 Filed
Jul 11, 2022
Case Assigned To Intent To Use Paralegal
Jun 1, 2022
Notice Of Revival - E-Mailed
May 31, 2022
Sou Extension Received With Teas Petition
May 31, 2022
Petition To Revive-Granted
May 31, 2022
Teas Petition To Revive Received
May 31, 2022
Teas Change Of Correspondence Received
May 31, 2022
Teas Change Of Domestic Representatives Address
May 31, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 31, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 23, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
May 23, 2022
Abandonment - No Use Statement Filed
Oct 19, 2021
Noa E-Mailed - Sou Required From Applicant
Aug 24, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 24, 2021
Published For Opposition
Aug 4, 2021
Notification Of Notice Of Publication E-Mailed
Jul 16, 2021
Approved For Pub - Principal Register
Jul 9, 2021
Teas/Email Correspondence Entered
Jul 9, 2021
Correspondence Received In Law Office
Jul 9, 2021
Teas Response To Office Action Received
Feb 22, 2021
Notification Of Non-Final Action E-Mailed
Feb 22, 2021
Non-Final Action E-Mailed
Feb 22, 2021
Non-Final Action Written
Feb 18, 2021
Assigned To Examiner
Nov 11, 2020
Notice Of Design Search Code E-Mailed
Nov 10, 2020
New Application Office Supplied Data Entered
Oct 1, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24